← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Distigminbromid currently has availability issues reported in 2 European registers: Germany, Greece.
Shortage ATC N07AA03 · also listed as: Distigminbromid · data refreshed 11 September 2026
As of 11 September 2026, 2 of the 9 tracked registers list current availability issues for Distigminbromid, covering 2 affected product presentations. The longest-running open report was filed in Germany on 2025-01-30 and has now been open for about 20 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-30. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Distigminbromid is coded N07AA03 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Ubretid Tabletten | 2025-01-30 | 2026-12-31 | Probleme beim Wirkstoffhersteller Alternatives: N/A | register ↗ |
| 🇬🇷 Greece | Limited availability Distigminbromid | 2026-07-03 | 2026-12-30 | Ν+Φ Ι.Φ.Ε.Τ. | register ↗ |
Every individual register entry for Distigminbromid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | Distigminbromid | Limited availability | 2026-07-03 | 2026-12-30 | Ν+Φ Ι.Φ.Ε.Τ. |
| 🇩🇪 DE | Ubretid Tabletten | Shortage | 2025-01-30 | 2026-12-31 | Probleme beim Wirkstoffhersteller |
Yes. As of 11 September 2026, availability issues are reported in: Germany, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-30 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Distigminbromid: BfArM (Germany), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Distigminbromid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/distigminbromid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Distigminbromid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/distigminbromid/">Distigminbromid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>